View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Analysis
June 10, 2022

Magazine: Continuous manufacturing cautiously builds on hype

In this issue: We check whether continuous manufacturing is building on its hype, the access to CAR-T therapies in Central and Eastern Europe, the emissions targets of pharma and biotech companies, and more.

By Manasi Vaidya

The latest issue of Pharma Technology Focus is out now. Read it for free on all devices.

More than two years since the pandemic began, the issue of building resilient supply chains remains front and centre in pharmaceutical company strategies. One potential way to address challenges is to consider a shift to continuous manufacturing from batch processes. In this month’s issue, we take a look at the hype surrounding continuous manufacturing, which has been positioned as a panacea, and assess the pace at which manufacturers are making this shift. A comment article also examines the impact of recent calls to make drug supply chain information public.  

Don’t miss an exclusive analysis of the emissions reduction targets of selected pharma and biotech companies, to see which entities are leading the way. 

All this, and the latest pharma industry news, comment, data and analysis from GlobalData

Read the latest issue of Pharma Technology Focus for all this and more news, insights, data and analysis from the pharmaceutical industry.

You can also subscribe here to receive email notifications when a new issue is available.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology